Live Breaking News & Updates on Corporate Development Legal Affairs

Viracta Therapeutics Strengthens Company Leadership with New Appointments to the Board of Directors and Management Team
Stephen Rubino, Ph.D., MBA and Barry J. Simon, M.D. appointed to the Board of Directors
Cheryl A. Madsen, RAC appointed as Senior Vice President, Regulatory Affairs
News provided by
Share this article
Share this article
SAN DIEGO, March 4, 2021 /PRNewswire/  Viracta Therapeutics, Inc. (Nasdaq: VIRX), a precision oncology company targeting virus-associated malignancies, today announced that it has strengthened its leadership team with the appointments of Drs. Stephen Rubino and Barry J. Simon to the Board of Directors, the addition of Cheryl A. Madsen, RAC as Senior Vice President, Regulatory Affairs, and the promotion of several members of the management team. ....

New York , United States , Cornell University , New York University , Ivor Royston , Cheryla Madsen , Calithera Biosciences , Roger Pomerantz , Uc Santa Cruz , Joyce Allaire , Cheryl Madsen , Michael Mueller , Dan Chevallard , Shelly Vandertie , Barryj Simon , Stephen Rubino , London School Of Business , North Sound Capital , Company Contact , Global Regulatory Affairs Certifications , Regulatory Affairs At Peloton Therapeutics , York University , Viracta Therapeutics Inc , Corporate Development Legal Affairs , Baruch College , Board Of Sermonix Pharmaceuticals ,